anifrolumab lupus nephritis

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
anifrolumab lupus nephritis	1.36	0.4	4005	74	27
anifrolumab	0.99	0.4	1386	17	11
lupus	1.81	0.7	1665	47	5
nephritis	1.73	0.4	1268	8	9

Keyword	CPC	PCC	Volume	Score
anifrolumab lupus nephritis	0.13	0.7	9424	3
anifrolumab lupus nephritis trial	1.31	0.4	3978	59
anifrolumab phase 2 lupus nephritis	1.71	0.5	3471	20
anifrolumab for lupus nephritis	0.51	0.9	4950	88
rituximab lupus nephritis trial	1.97	0.8	3844	7
lupus nephritis clinical trials	0.97	0.4	8086	71
alms trial lupus nephritis	0.06	0.4	5789	49
belimumab in lupus nephritis	0.16	0.3	4752	92
nobility trial lupus nephritis	1.03	0.4	16	92
new medication trial for lupus	0.99	0.3	130	50
obinutuzumab in lupus nephritis	0.43	0.2	9479	84
landmark trials in lupus nephritis	1.88	0.3	7660	75
daratumumab in lupus nephritis	0.2	0.2	2046	60
new treatments for lupus nephritis	1.52	0.3	6600	82
lupus nephritis approved drugs	1.14	0.6	8532	62
new drugs for lupus nephritis	0.94	0.3	2752	47
lupus nephritis case study	1.76	0.6	7894	31
rituximab for lupus nephritis	0.67	0.2	2280	12
lupus nephritis treatment 2023	1.91	0.5	4751	36
lupus nephritis new treatment	0.08	0.2	454	47
lupus nephritis review article	0.37	0.9	571	45
clinical trials for lupus	0.69	0.7	4097	42
clinical trials for lupus patients	1.2	0.9	3364	1
clinical trials for lupus treatment	1.69	0.6	8027	74